Logo image of DYA.CA

DYNACERT INC (DYA.CA) Stock Fundamental Analysis

TSX:DYA - CA26780A1084 - Common Stock

0.13 CAD
+0.01 (+4%)
Last: 8/29/2025, 7:00:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to DYA. DYA was compared to 16 industry peers in the Electrical Equipment industry. Both the profitability and financial health of DYA have multiple concerns. DYA has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

DYA had negative earnings in the past year.
In the past year DYA has reported a negative cash flow from operations.
DYA had negative earnings in each of the past 5 years.
In the past 5 years DYA always reported negative operating cash flow.
DYA.CA Yearly Net Income VS EBIT VS OCF VS FCFDYA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

DYA has a Return On Assets of -242.21%. This is in the lower half of the industry: DYA underperforms 75.00% of its industry peers.
Industry RankSector Rank
ROA -242.21%
ROE N/A
ROIC N/A
ROA(3y)-201.12%
ROA(5y)-150.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DYA.CA Yearly ROA, ROE, ROICDYA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for DYA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DYA.CA Yearly Profit, Operating, Gross MarginsDYA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K -10K

0

2. Health

2.1 Basic Checks

DYA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DYA has more shares outstanding
The number of shares outstanding for DYA has been increased compared to 5 years ago.
The debt/assets ratio for DYA is higher compared to a year ago.
DYA.CA Yearly Shares OutstandingDYA.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
DYA.CA Yearly Total Debt VS Total AssetsDYA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of -32.33, we must say that DYA is in the distress zone and has some risk of bankruptcy.
DYA has a Altman-Z score of -32.33. This is amonst the worse of the industry: DYA underperforms 87.50% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -32.33
ROIC/WACCN/A
WACC8.01%
DYA.CA Yearly LT Debt VS Equity VS FCFDYA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 0.51 indicates that DYA may have some problems paying its short term obligations.
With a Current ratio value of 0.51, DYA is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
A Quick Ratio of 0.24 indicates that DYA may have some problems paying its short term obligations.
DYA has a Quick ratio of 0.24. This is in the lower half of the industry: DYA underperforms 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.51
Quick Ratio 0.24
DYA.CA Yearly Current Assets VS Current LiabilitesDYA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

6

3. Growth

3.1 Past

The earnings per share for DYA have decreased strongly by -58.64% in the last year.
DYA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.18%.
Measured over the past years, DYA shows a quite strong growth in Revenue. The Revenue has been growing by 8.61% on average per year.
EPS 1Y (TTM)-58.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10.87%
Revenue 1Y (TTM)15.18%
Revenue growth 3Y28.22%
Revenue growth 5Y8.61%
Sales Q2Q%-92.89%

3.2 Future

DYA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 55.65% yearly.
The Revenue is expected to grow by 263.86% on average over the next years. This is a very strong growth
EPS Next Y100%
EPS Next 2Y55.65%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year656.55%
Revenue Next 2Y263.86%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DYA.CA Yearly Revenue VS EstimatesDYA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
DYA.CA Yearly EPS VS EstimatesDYA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2026 0 -0.02 -0.04

4

4. Valuation

4.1 Price/Earnings Ratio

DYA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 12.87, DYA is valued correctly.
Based on the Price/Forward Earnings ratio, DYA is valued cheaper than 81.25% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of DYA to the average of the S&P500 Index (22.72), we can say DYA is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 12.87
DYA.CA Price Earnings VS Forward Price EarningsDYA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DYA.CA Per share dataDYA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0.01 -0.02

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as DYA's earnings are expected to grow with 55.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y55.65%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

DYA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DYNACERT INC

TSX:DYA (8/29/2025, 7:00:00 PM)

0.13

+0.01 (+4%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)08-13 2025-08-13
Earnings (Next)11-12 2025-11-12
Inst Owners5.16%
Inst Owner ChangeN/A
Ins Owners8.23%
Ins Owner ChangeN/A
Market Cap66.08M
Analysts84
Price Target0.77 (492.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 12.87
P/S 56.4
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)0.01
Fwd EY7.77%
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -242.21%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-201.12%
ROA(5y)-150.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.34%
Cap/Sales 1.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.51
Quick Ratio 0.24
Altman-Z -32.33
F-Score3
WACC8.01%
ROIC/WACCN/A
Cap/Depr(3y)6.19%
Cap/Depr(5y)101.41%
Cap/Sales(3y)7.56%
Cap/Sales(5y)101.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-58.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10.87%
EPS Next Y100%
EPS Next 2Y55.65%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)15.18%
Revenue growth 3Y28.22%
Revenue growth 5Y8.61%
Sales Q2Q%-92.89%
Revenue Next Year656.55%
Revenue Next 2Y263.86%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-68.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year117.62%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-42.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-43.95%
OCF growth 3YN/A
OCF growth 5YN/A